Position in ACOG
as of Dec 31, 2025
· filed Jan 7, 2026
Position Value
$72,319
New position
Shares Held
11,126
first reported quarter
Ownership
0.051%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Green Alpha Advisors, LLC holds $7,875,497 across 13 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
57,022 | $2,712,536 | |
| 2 | MRNA |
Moderna, Inc.
|
34,338 | $1,744,370 | |
| 3 | CRBU |
Caribou Biosciences, Inc.
|
373,650 | $709,935 | |
| 4 | PRME |
Prime Medicine, Inc.
|
191,171 | $665,275 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
152,098 | $466,940 | |
| 6 | EDIT |
Editas Medicine, Inc.
|
160,142 | $395,550 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
336 | $259,607 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
546 | $243,810 |
All Filings in ACOG
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $72,319 | 11,126 | Shares | Sole | 2026-01-07 | |
| No filing history on record for this holder in this stock. | ||||||